KNC Laboratories

6568.TServices

Key numbers · FY ended 2026-03

Revenue¥9.1bn+11.2% YoY Operating income¥1.0bn+32.7% YoY Total assets¥21.6bn+7.4% YoY EPS (basic)¥99.02+3.8% YoY

Full financial history and reports →

Stock price6568 · View chart ↗

Open the price chart on TradingView.

Latest filings

Mon, Sep 7 · JST1 filing

14:17MATERIALKNC Laboratories · Change in major shareholder

Thu, Oct 23 · JST3 filings

16:295% STAKEKNC Laboratories · KNC Kosan Co., Ltd. + 1 joint holder · 37.73% → 28.73%−9.00pp 15:575% STAKEKNC Laboratories · KNC Kosan Co., Ltd. + 1 joint holder · 39.18% → 37.73%−1.45pp 15:525% STAKEKNC Laboratories · KNC Kosan Co., Ltd. + 1 joint holder · 41.38% → 39.18%−2.20pp

Mon, Oct 20 · JST1 filing

14:155% STAKEKNC Laboratories · KNC HIROSE FOUNDATION · 9.00%new 9.00%

All filings →

Major holders (5%+) · 4

Holder	Stake	Change	Filed
KNC Kosan Co., Ltd.	19.43%	0.00pp	2025-10-23
Hitoshi Miyauchi	10.45%	—	2025-06-26
Hirose Katsutoshi	9.30%	-9.00pp	2025-10-23
KNC HIROSE FOUNDATION	9.00%	—	2025-10-20

Each holder's own ratio from its most recent large-shareholding report.